Related Experiment Video

Updated: Aug 12, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Hypothetical hypercholesterolaemia and atherosclerosis

W E Stehbens1

  • 1Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, PO Box 7343, Wellington South, Wellington, New Zealand. wstehbens@wnmeds.ac.nz

Medical Hypotheses
|January 20, 2004
PubMed

Insights

This study challenges the hypercholesterolaemia/lipid hypothesis for coronary heart disease, citing flawed data and methodology. It calls for precise terminology and closer scientific surveillance of atherosclerosis research.

Area of Science:

  • Pathology
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • Recent pathological research in atherosclerosis and epidemiological reviews of coronary heart disease.
  • Identified significant data fallacies and methodological errors in existing research.

Purpose of the Study:

  • Critically review the epidemiology of coronary heart disease.
  • Examine pathological advances in experimental and iatrogenic atherosclerosis.
  • Address the underlying issues within the hypercholesterolaemia/lipid hypothesis.

Main Methods:

  • Critical review of epidemiological data on coronary heart disease.
  • Analysis of pathological findings in experimental and iatrogenic atherosclerosis.
  • Evaluation of the misuse of risk factors and surrogates in lipid hypothesis research.

Main Results:

  • Fallacious data and methodological errors were found in studies supporting the hypercholesterolaemia/lipid hypothesis.
  • Misinterpretation of cholesterol's role in atherogenesis is prevalent.
  • Inappropriate use of risk factors and surrogates distorts understanding.

Conclusions:

  • Greater precision in terminology is required for atherosclerosis research.
  • Reinstitution of statistical reference ranges for cholesterol is necessary.
  • Closer scientific surveillance of etiological research in medicine is essential.

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...